TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19836153

Group type: EXPERIMENTAL
Intervention: 40 Gy in 20 twice‐daily fractions (Arm A)
Number of subjects: 113

Group type: COMPARATOR
Intervention: 20 Gy in four daily fractions (Arm B)
Number of subjects: 113
Study: 18456678

Group type: EXPERIMENTAL
Intervention: Icodextrin
Number of subjects: 50

Group type: COMPARATOR
Intervention: Glucose
Number of subjects: 50
Study: 16958184

Group type: EXPERIMENTAL
Intervention: Randomization before consent
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard consent process
Number of subjects: 0
Study: 14871033

Group type: EXPERIMENTAL
Intervention: Valsartan (V group, n = 36)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Amlodipine (A group, n = 37)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 73
Study: 10976537

Group type: EXPERIMENTAL
Intervention: Filgrastim 300 microg/day administered on days 1, 3, and 5 in weeks 2-6 of radiotherapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Accelerated hyperfractionated radiotherapy (1.6 Gy b.i.d., total dose 67.2 Gy in six weeks with a two-week split) and concomitant chemotherapy (cisplatin, 20 mg/m2/day, days 1-5 by continuous intravenous infusion)
Number of subjects: 20
Study: 8922358

Group type: EXPERIMENTAL
Intervention: Glomerular hyperfiltration (GFR >135 ml x min(‐1) x 1.73 m(‐2))
Number of subjects: 50

Group type: COMPARATOR
Intervention: Glomerular normofiltration (GFR 83‐135 ml x min(‐1) x 1.73 m(‐2))
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study: 1319875

Group type: EXPERIMENTAL
Intervention: Maalox 70 (antacid)
Number of subjects: 12
Study: 6375874

Group type: EXPERIMENTAL
Intervention: Domperidone 20 mg
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Domperidone 30 mg
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Domperidone 40 mg
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Domperidone (all doses)
Number of subjects: 19
Study: 31604480

Group type: COMPARATOR
Intervention: Once Daily (OD) screening
Number of subjects: 760

Group type: EXPERIMENTAL
Intervention: At least Twice Daily (ALTD) screening
Number of subjects: 760

Group type: EXPERIMENTAL
Intervention: Pressure Support (PS) + Positive End‐Expiratory Pressure (PEEP) SBT technique
Number of subjects: 760

Group type: EXPERIMENTAL
Intervention: T-piece SBT technique
Number of subjects: 760
Study: 28599588

Group type: EXPERIMENTAL
Intervention: Happier Meals vicarious learning video
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control video about education
Number of subjects: 50
Study: 27112434

Group type: EXPERIMENTAL
Intervention: Squeezing a soft ball
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Balloon inflation
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Distraction cards
Number of subjects: 120
Study: 24439465

Group type: EXPERIMENTAL
Intervention: EBUS plus fluoroscopy
Number of subjects: 145

Group type: COMPARATOR
Intervention: Fluoroscopy alone
Number of subjects: 145
Study: 22542645

Group type: EXPERIMENTAL
Intervention: Concise informed consent form
Number of subjects: 111

Group type: COMPARATOR
Intervention: Standard informed consent form
Number of subjects: 111
Study: 19562446

Group type: EXPERIMENTAL
Intervention: Aloe vera cream
Number of subjects: 30

Group type: COMPARATOR
Intervention: Silver sulfadiazine (SSD)
Number of subjects: 30
Study: 17251214

Group type: EXPERIMENTAL
Intervention: Oral pregabalin (titrated to 300 mg)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Aprepitant (titrated to 320 mg)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Pregabalin + parecoxib (40 mg)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Aprepitant + parecoxib (40 mg)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 15235348

Group type: EXPERIMENTAL
Intervention: Nasal polyposis patients
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study: 11855527

Group type: EXPERIMENTAL
Intervention: Healing Touch (HT)
Number of subjects: 0
Study: 9603635

Group type: EXPERIMENTAL
Intervention: Meropenem (20 mg/kg t.i.d. i.v.)
Number of subjects: 185

Group type: COMPARATOR
Intervention: Ceftazidime (10-30 mg/kg t.i.d. i.v.)
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Meropenem
Number of subjects: 185

Group type: COMPARATOR
Intervention: Ceftazidime
Number of subjects: 185
Study: 7802179

Group type: EXPERIMENTAL
Intervention: 25 G Whitacre needle
Number of subjects: 212

Group type: COMPARATOR
Intervention: 27 G Whitacre needle
Number of subjects: 212
Study: 3052815

Group type: EXPERIMENTAL
Intervention: Dextrofenfluramine
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 31305011

Group type: EXPERIMENTAL
Intervention: AS04-HPV-16/18 vaccine
Number of subjects: 6051

Group type: COMPARATOR
Intervention: Al(OH)3 (control)
Number of subjects: 6051
Study: 25272321

Group type: EXPERIMENTAL
Intervention: Frequent abdominal pain (≥2/month)
Number of subjects: 420

Group type: COMPARATOR
Intervention: Infrequent abdominal pain (<2/month)
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: Female gender
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: Emotional overeating
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: Parental depression
Number of subjects: 420
Study: 22973890

Group type: EXPERIMENTAL
Intervention: Self-care promoting problem-based learning programme (experimental group)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 202
Study: 21732734

Group type: EXPERIMENTAL
Intervention: CranioSacral therapy (CST)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Low-strength static magnet (LSSM)
Number of subjects: 65
Study: 19845810

Group type: EXPERIMENTAL
Intervention: Culturally tailored diabetes intervention
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Focus group
Number of subjects: 20
Study: 16753947

Group type: EXPERIMENTAL
Intervention: 1.5 mg melatonin (Melaxen) daily at 22:30 h for 2 weeks
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study: 15774704

Group type: EXPERIMENTAL
Intervention: Korean Asians (Ko‐As)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Caucasians (Ca)
Number of subjects: 88
Study: 12042193

Group type: EXPERIMENTAL
Intervention: Risperidone plus 400 mg/day of celecoxib
Number of subjects: 50

Group type: COMPARATOR
Intervention: Risperidone plus placebo
Number of subjects: 50
Study: 9873970

Group type: EXPERIMENTAL
Intervention: Epidural fentanyl (25, 50, 75, or 100 micrograms) with bupivacaine 0.125%
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Epidural sufentanil (5, 10, 15, 20, or 25 micrograms) with bupivacaine 0.125%
Number of subjects: 100

Group type: COMPARATOR
Intervention: Epidural bupivacaine 0.125% alone
Number of subjects: 100
Study: 7840317

Group type: EXPERIMENTAL
Intervention: High-dose arginine vasopressin (AVP) at rates of 500, 1,000, 2,000, and 4,000 microU.kg‐1.min‐1
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: V1-receptor blockade during high-dose AVP
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Low-dose arginine vasopressin (AVP)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Plasma renin activity (PRA)
Number of subjects: 18
Study: 1973907

Group type: EXPERIMENTAL
Intervention: Formoterol (12 micrograms)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Formoterol (24 micrograms)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Salbutamol (200 micrograms)
Number of subjects: 13
Study: 946580

Group type: EXPERIMENTAL
Intervention: Intravenous cortisol (1,000 mg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Intramuscular betamethasone (12.0 mg)
Number of subjects: 14
Study: 30838423

Group type: EXPERIMENTAL
Intervention: Fathers employed in painting industries
Number of subjects: 1999

Group type: EXPERIMENTAL
Intervention: Fathers employed in printing industries
Number of subjects: 1999

Group type: EXPERIMENTAL
Intervention: Fathers employed in painting and printing industries combined
Number of subjects: 1999

Group type: EXPERIMENTAL
Intervention: Mothers employed in painting industries
Number of subjects: 1999

Group type: EXPERIMENTAL
Intervention: Mothers employed in painting and printing industries combined
Number of subjects: 1999

Group type: EXPERIMENTAL
Intervention: Fathers employed in combined painting and printing industries
Number of subjects: 1999
Study: 29035297

Group type: EXPERIMENTAL
Intervention: Isolated Lumbar Extension (ILEX) resistance training for 12 weeks
Number of subjects: 77
Study: 25110847

Group type: EXPERIMENTAL
Intervention: Depressive symptoms
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Medication beliefs
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Higher depressive symptoms
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Positive medication beliefs
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Medication adherence
Number of subjects: 128
Study: 24145618

Group type: EXPERIMENTAL
Intervention: 12‐month parent‐centred intervention involving self‐directed education provided in CD and DVD formats
Number of subjects: 146

Group type: COMPARATOR
Intervention: Participant‐blinded control group who received generic nutrition and physical activity information
Number of subjects: 146
Study: 21648282

Group type: EXPERIMENTAL
Intervention: Collagen + Calcium (G-III, n=22)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Collagen (G-II, n=20)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (G-I, n=18)
Number of subjects: 60
Study: 19422580

Group type: EXPERIMENTAL
Intervention: Single-site BB pacing
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: RAA+CS pacing
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: BB+CS pacing
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: CS pacing
Number of subjects: 57

Group type: COMPARATOR
Intervention: Sinus rhythm (SR)
Number of subjects: 57
Study: 16898234

Group type: EXPERIMENTAL
Intervention: Exercise intervention (13 weeks, at leisure time, in off‐worksite training facilities)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 110
Study: 15315591

Group type: EXPERIMENTAL
Intervention: Congenital thrombophilia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prophylactic antithrombotic treatment
Number of subjects: 0
Study: 11231232

Group type: EXPERIMENTAL
Intervention: Poliglecaprone 25 sutures
Number of subjects: 22

Group type: COMPARATOR
Intervention: Metal staples
Number of subjects: 22
Study: 9447569

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba special extract EGb 761 (240 mg/day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 8162662

Group type: EXPERIMENTAL
Intervention: Smoking one tobacco cigarette
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo cigarette
Number of subjects: 85
Study: 3258200

Group type: EXPERIMENTAL
Intervention: Intravenous polymyxin B for 5 days in addition to standard therapy
Number of subjects: 13

Group type: COMPARATOR
Intervention: Standard therapy alone
Number of subjects: 13

Group type: COMPARATOR
Intervention: Sera from burn patients
Number of subjects: 13

Group type: COMPARATOR
Intervention: Affinity chromatography to remove endotoxin from sera
Number of subjects: 13
Study: 31856812

Group type: EXPERIMENTAL
Intervention: App group (n = 100)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: App+Feedback group (n = 100)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Usual Care group (n = 100)
Number of subjects: 300
Study: 28249254

Group type: EXPERIMENTAL
Intervention: ViE-coated polysulfone dialyzer
Number of subjects: 93

Group type: COMPARATOR
Intervention: Low-flux synthetic dialyzer (Control)
Number of subjects: 93
Study: 25418186

Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg twice daily
Number of subjects: 666

Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg twice daily
Number of subjects: 666

Group type: COMPARATOR
Intervention: Tofacitinib 5 mg (withdrawal)
Number of subjects: 666

Group type: COMPARATOR
Intervention: Tofacitinib 10 mg (withdrawal)
Number of subjects: 666

Group type: COMPARATOR
Intervention: Placebo (5 mg)
Number of subjects: 666

Group type: COMPARATOR
Intervention: Placebo (10 mg)
Number of subjects: 666

Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg (retreatment)
Number of subjects: 666

Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg (retreatment)
Number of subjects: 666
Study: 23280480

Group type: EXPERIMENTAL
Intervention: Cardiac surgery with left atrial ablation
Number of subjects: 224

Group type: COMPARATOR
Intervention: Cardiac surgery alone
Number of subjects: 224
Study: 21567262

Group type: EXPERIMENTAL
Intervention: Laparoscopic colectomy (group B)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Open colectomy (group A)
Number of subjects: 40
Study: 18267029

Group type: EXPERIMENTAL
Intervention: Positive expectation instructional set
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Negative expectation instructional set
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Neutral expectation instructional set
Number of subjects: 60
Study: 16807257

Group type: EXPERIMENTAL
Intervention: Lidocaine spray
Number of subjects: 185

Group type: COMPARATOR
Intervention: Placebo spray
Number of subjects: 185
Study: 12971846

Group type: EXPERIMENTAL
Intervention: Traditional craniotomy
Number of subjects: 112

Group type: COMPARATOR
Intervention: Puncture drainage and urokinase treatment
Number of subjects: 112
Study: 11208407

Group type: EXPERIMENTAL
Intervention: Clemastine (2 mg i.v.)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control (no clemastine)
Number of subjects: 53
Study: 9410280

Group type: EXPERIMENTAL
Intervention: Hypercapnic stimulation in OSA patients (OSA-N)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Hypercapnic stimulation in OSA patients (OSA-H)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Isocapnic hypoxic stimulation in OSA patients (OSA-H)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Isocapnic hypoxic stimulation in OSA patients (OSA-N)
Number of subjects: 37
Study: 1611416

Group type: EXPERIMENTAL
Intervention: 3D CT
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Axial CT
Number of subjects: 16

Group type: COMPARATOR
Intervention: Plain radiography
Number of subjects: 16
Study: 3903970

Group type: EXPERIMENTAL
Intervention: S-carboxy-methyl-L-cysteine, 750 mg three times daily for three days before examination
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 103
Study: 31542565

Group type: EXPERIMENTAL
Intervention: Deprexis® (internet-based intervention)
Number of subjects: 1013

Group type: COMPARATOR
Intervention: Care as usual (control group)
Number of subjects: 1013
Study: 29895874

Group type: EXPERIMENTAL
Intervention: Active intermittent theta-burst stimulation (iTBS) over the hand representation of the primary motor cortex, delivered in 10 sessions over a 2-week period.
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham intermittent theta-burst stimulation (iTBS) over the hand representation of the primary motor cortex, delivered in 10 sessions over a 2-week period.
Number of subjects: 12
Study: 27461586

Group type: EXPERIMENTAL
Intervention: Cone-beam CT navigation
Number of subjects: 58

Group type: COMPARATOR
Intervention: Conventional CT
Number of subjects: 58
Study: 24840511

Group type: COMPARATOR
Intervention: sn-2 formula
Number of subjects: 300

Group type: COMPARATOR
Intervention: sn-2+3 g/L OF
Number of subjects: 300

Group type: COMPARATOR
Intervention: sn-2+5 g/L OF
Number of subjects: 300
Study: 22607546

Group type: EXPERIMENTAL
Intervention: Tailored treatment (T)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Non-tailored treatment (NT)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 120
Study: 21033121

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT) for periarthritis of shoulder
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT) for tennis elbow
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group for periarthritis of shoulder
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group for tennis elbow
Number of subjects: 120
Study: 19016938

Group type: EXPERIMENTAL
Intervention: Moderate-intensity physical activity (PA) intervention
Number of subjects: 424

Group type: COMPARATOR
Intervention: Successful aging (SA) health education intervention
Number of subjects: 424
Study: 15750044

Group type: EXPERIMENTAL
Intervention: Electronic nose analysis of exhaled breath
Number of subjects: 59
Study: 12584790

Group type: EXPERIMENTAL
Intervention: Shengmai Injection (SMI)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 100
Study: 11853012

Group type: EXPERIMENTAL
Intervention: Saline instillation prior to suctioning
Number of subjects: 17

Group type: COMPARATOR
Intervention: No saline instillation prior to suctioning
Number of subjects: 17
Study: 9130752

Group type: EXPERIMENTAL
Intervention: Glass wool filtration
Number of subjects: 25

Group type: COMPARATOR
Intervention: Percoll density gradient
Number of subjects: 25
Study: 8213303

Group type: EXPERIMENTAL
Intervention: Nicotine gum
Number of subjects: 3923
Study: 3565663

Group type: EXPERIMENTAL
Intervention: Single mailed influenza vaccination cue
Number of subjects: 2217
Study: 30032861

Group type: EXPERIMENTAL
Intervention: Hand files up to file 40/.02
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Mtwo rotary files up to files 40/.04
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Mtwo rotary files up to files 40/.06
Number of subjects: 58

Group type: COMPARATOR
Intervention: Uninstrumented control group
Number of subjects: 58
Study: 28860228

Group type: EXPERIMENTAL
Intervention: Anterior transversalis fascia approach
Number of subjects: 720

Group type: COMPARATOR
Intervention: Preperitoneal space approach
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: Both approaches
Number of subjects: 720
Study: 26444221

Group type: EXPERIMENTAL
Intervention: Hypothermia (32 to 35°C) plus standard care
Number of subjects: 387

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 387
Study: 23192219

Group type: EXPERIMENTAL
Intervention: Mandated to community-based outpatient treatment
Number of subjects: 160

Group type: COMPARATOR
Intervention: Voluntary entry into treatment
Number of subjects: 160
Study: 21245238

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 89

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 89
Study: 19256057

Group type: EXPERIMENTAL
Intervention: Antibacterial treatment plus wardenafil (10 mg in the evening)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Combined treatment (fluoroquinolone + wardenafil)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Levofloxacine (500 mg/day) monotherapy for 4 weeks
Number of subjects: 103
Study: 16921688

Group type: EXPERIMENTAL
Intervention: Conventional ultrafiltration (CUF)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Non-CUF (control)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: CUF
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: CUF and Non-CUF
Number of subjects: 96
Study: 12671884

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 11192957

Group type: EXPERIMENTAL
Intervention: Nebulized fluticasone propionate (1 mg b.d.)
Number of subjects: 321

Group type: COMPARATOR
Intervention: Oral prednisolone (2 mg kg(‐1) day(‐1) for 4 days then 1 mg kg(‐1) day(‐1) for 3 days)
Number of subjects: 321
Study: 9198507

Group type: EXPERIMENTAL
Intervention: No fluid or solids for at least four hours before the injection (Group A, 499 cases)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Unlimited food and fluid (Group B, 501 cases)
Number of subjects: 1000
Study: 1586386

Group type: EXPERIMENTAL
Intervention: 3.5 g omega‐3 fatty acids/day
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 7.1 g omega‐3 fatty acids/day
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 10.6 g omega‐3 fatty acids/day
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 29248101

Group type: EXPERIMENTAL
Intervention: Ultrasound-assisted thrombolysis (USAT) catheter
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard catheter-directed thrombolysis (SCDT) catheter
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: USAT catheter
Number of subjects: 80

Group type: COMPARATOR
Intervention: SCDT catheter
Number of subjects: 80
Study: 28510679

Group type: EXPERIMENTAL
Intervention: Intra-articular triamcinolone (40 mg every 12 weeks for 2 years)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Saline (every 12 weeks for 2 years)
Number of subjects: 140
Study: 26241420

Group type: EXPERIMENTAL
Intervention: Myo-inositol (2 g plus 200 micrograms folic acid twice a day)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Placebo (200 micrograms folic acid twice a day)
Number of subjects: 220
Study: 23810050

Group type: EXPERIMENTAL
Intervention: Low‐viscosity light‐cured resin infiltration after enamel conditioning with a 15% HCl gel
Number of subjects: 21

Group type: COMPARATOR
Intervention: No therapy (control group)
Number of subjects: 21
Study: 21138531

Group type: EXPERIMENTAL
Intervention: Transdermal buprenorphine (20 μg/hr, 144 hr)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Transdermal fentanyl (25 μg/hr, 72 hr)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 18826873

Group type: EXPERIMENTAL
Intervention: PITT (psychodynamically oriented inpatient treatment program)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: PITT
Number of subjects: 84

Group type: COMPARATOR
Intervention: Wait-list control (treatment as usual)
Number of subjects: 84
Study: 16672309

Group type: EXPERIMENTAL
Intervention: 4 day food records (FRs)
Number of subjects: 1809

Group type: COMPARATOR
Intervention: Food frequency questionnaires (FFQ)
Number of subjects: 1809
Study: 14594781

Group type: EXPERIMENTAL
Intervention: Supervised aerobic exercise (45 min/d, 5 d/wk)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 74
Study: 10793606

Group type: EXPERIMENTAL
Intervention: Gelofusine 500 ml over 15 min
Number of subjects: 20

Group type: COMPARATOR
Intervention: No fluid preload
Number of subjects: 20
Study: 8972009

Group type: EXPERIMENTAL
Intervention: Monitoring of anticoagulation by kaolin ACT combined with on-site measurements of whole blood heparin concentration (Intervention, n = 15)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Monitoring of anticoagulation by celite ACT (Control, n = 16)
Number of subjects: 31